Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ROBERT S. BARRY, M.D., INC

NPI: 1366574048 · SANTA MARIA, CA 93454 · Pediatrics Physician · NPI assigned 03/09/2007

$8.35M
Total Medicaid Paid
208,787
Total Claims
194,656
Beneficiaries
68
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBARRY, ROBERT (M.D.)
NPI Enumeration Date03/09/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 30,026 $658K
2019 33,331 $1.13M
2020 24,712 $1.14M
2021 32,518 $1.59M
2022 34,650 $1.80M
2023 36,042 $1.34M
2024 17,508 $691K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
96156 14,450 13,438 $1.49M
96110 Developmental screening, with scoring and documentation, per standardized instrument 15,762 12,389 $1.41M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 18,113 15,937 $696K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 7,703 7,361 $691K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 6,784 6,239 $581K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18,934 17,722 $554K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,926 4,896 $473K
99051 5,668 5,366 $418K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 3,211 3,197 $352K
90671 1,134 1,042 $257K
92551 11,315 11,190 $154K
96150 6,075 5,128 $135K
99381 995 968 $109K
H0049 Alcohol and/or drug screening 2,808 2,800 $83K
90686 6,659 6,578 $78K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,915 1,855 $76K
D1206 Topical application of fluoride varnish 3,264 3,095 $72K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 629 619 $63K
90670 4,919 4,582 $61K
97802 1,559 1,524 $58K
90723 4,900 4,555 $56K
90647 4,713 4,390 $52K
85018 18,452 17,933 $47K
G9920 Screening performed and negative 3,121 3,040 $41K
90633 2,839 2,707 $32K
90681 2,692 2,457 $32K
99173 7,537 7,493 $26K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,737 1,625 $25K
99188 973 895 $21K
90651 1,475 1,467 $21K
90734 1,117 1,109 $15K
90716 1,109 1,045 $14K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 928 448 $11K
96127 2,039 1,956 $11K
90707 911 859 $10K
86580 1,994 1,867 $10K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 59 59 $9K
90700 807 756 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 140 133 $9K
90710 712 702 $9K
98967 329 296 $8K
90696 652 642 $7K
99000 2,027 1,972 $7K
90715 595 594 $7K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 51 50 $5K
87807 366 314 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 784 711 $4K
G9919 Screening performed and positive and provision of recommendations 352 341 $4K
0071A 99 99 $4K
87634 52 51 $4K
0072A 82 82 $3K
90656 265 265 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 175 158 $2K
99384 13 13 $2K
90672 231 231 $2K
90620 142 142 $2K
99383 12 12 $2K
90688 69 66 $740.85
81002 7,195 6,999 $673.14
0051A 14 14 $560.00
90685 15 14 $409.46
99215 Prolong outpt/office vis 16 15 $380.76
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 18 18 $328.68
90744 19 18 $244.70
90648 22 21 $226.98
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 13 12 $204.10
90713 13 12 $143.91
99177 88 72 $0.00